Skip to main content

Endurant Capital Management LP

13F filer · CIK 0001633055
Last filed May 7, 2024
Inactive · not filing 13F
13F portfolio value$0U.S. long equity reported on 13F
Positions00 new · 24 closed
Net flow last quarter-$17.8MBuys minus sells
Top 10 positions weightNot reportedConcentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q1 2024Reported May 7, 20240 positions
Q4 2023Reported Feb 14, 202424 positions
BSXBoston Scientific Corp$2.26M12.96%0.00%-18.3%Q4 2014
TMOThermo Fisher Scientific Inc.$2.01M11.55%0.00%-72.6%Q4 2014
AXNXAxonics, Inc.$1.55M8.87%0.05%Not reportedQ3 2019
ELVElevance Health, Inc.$1.24M7.10%0.00%-80.5%Q4 2014
ICLRIcon PLC$1.04M5.94%0.00%Not reportedQ1 2018
EHCEncompass Health Corp$859K4.92%0.01%Not reportedQ4 2018
PODDInsulet Corp$848K4.86%0.01%-56.0%Q1 2015
HOLXHologic Inc$831K4.76%0.00%-34.5%Q4 2014
ZBHZimmer Biomet Holdings, Inc.$687K3.94%0.00%-67.7%Q4 2014
AVTRAvantor, Inc.$562K3.22%0.00%-89.2%Q1 2020
THCTenet Healthcare Corp$552K3.16%0.01%-73.1%Q1 2019
PFEPfizer Inc$455K2.61%0.00%Not reportedQ4 2014
BMRNBiomarin Pharmaceutical Inc$448K2.57%0.00%-97.4%Q1 2017
KIDSOrthopediatrics Corp$437K2.50%0.06%-80.9%Q3 2020
CICigna Group$414K2.38%0.00%-77.3%Q4 2014
QDELQuidelOrtho Corp$379K2.17%0.01%-80.8%Q4 2014
COOCooper Companies, Inc.$374K2.14%0.00%-91.4%Q2 2018
SBRASabra Health Care REIT, Inc.$286K1.64%0.01%-90.2%Q3 2017
AAgilent Technologies, Inc.$264K1.51%0.00%Not reportedQ4 2014
FTREFortrea Holdings Inc.$244K1.40%0.01%NewQ4 2023
QGENQiagen N.V.$227K1.30%0.00%Not reportedQ2 2015
HUMHumana Inc$215K1.23%0.00%-92.9%Q4 2014
CORCencora, Inc.$203K1.17%0.00%-91.5%Q4 2014
ACRSAclaris Therapeutics, Inc.$156K0.89%0.21%Not reportedQ1 2019
Q3 2023Reported Nov 14, 202341 positions
BMRNBiomarin Pharmaceutical Inc$15.9M14.27%0.10%+311.8%Q1 2017
TMOThermo Fisher Scientific Inc.$7.01M6.30%0.00%Not reportedQ4 2014
BRKRBruker Corp$6.93M6.23%0.08%+629.9%Q1 2015
AZNAstrazeneca PLC$6.53M5.87%Not reported+58.6%Q2 2019
ELVElevance Health, Inc.$5.88M5.28%0.01%+139.6%Q4 2014
AVTRAvantor, Inc.$4.78M4.30%0.03%Not reportedQ1 2020
MRKMerck & Co., Inc.$4.57M4.10%0.00%-10.0%Q4 2014
ARGXArgenx SE$4.48M4.02%0.02%+255.1%Q1 2022
CNMDCONMED Corp$4.23M3.80%0.14%Not reportedQ1 2016
COOCooper Companies, Inc.$3.67M3.29%0.02%Not reportedQ2 2018
HUMHumana Inc$3.2M2.88%0.01%Not reportedQ4 2014
TXG10x Genomics, Inc.$2.93M2.63%0.06%Not reportedQ1 2022
SBRASabra Health Care REIT, Inc.$2.84M2.55%0.09%Not reportedQ3 2017
OHIOmega Healthcare Investors Inc$2.66M2.38%0.03%Not reportedQ3 2022
BSXBoston Scientific Corp$2.53M2.27%0.00%-21.5%Q4 2014
KIDSOrthopediatrics Corp$2.25M2.02%0.30%+555.1%Q3 2020
CORCencora, Inc.$2.09M1.88%0.01%Not reportedQ4 2014
SYKStryker Corp$2.06M1.85%0.00%Not reportedQ4 2014
INSMINSMED Inc$2.01M1.80%0.06%Not reportedQ3 2017
ZBHZimmer Biomet Holdings, Inc.$1.96M1.76%0.01%Not reportedQ4 2014
QDELQuidelOrtho Corp$1.95M1.75%0.04%Not reportedQ4 2014
DXCMDexcom Inc$1.93M1.73%0.01%Not reportedQ2 2022
THCTenet Healthcare Corp$1.79M1.61%0.03%-53.2%Q1 2019
ABTAbbott Laboratories$1.75M1.57%0.00%Not reportedQ4 2014
CICigna Group$1.74M1.56%0.00%-76.4%Q4 2014
PODDInsulet Corp$1.42M1.27%0.01%Not reportedQ1 2015
ETNB89bio, Inc.$1.27M1.14%0.11%+180.6%Q4 2022
HOLXHologic Inc$1.23M1.11%0.01%Not reportedQ4 2014
OCULOcular Therapeutix, Inc$1.11M1.00%0.45%-4.0%Q1 2018
AZTAAzenta, Inc.$975K0.88%0.03%NewQ3 2023
TARSTarsus Pharmaceuticals, Inc.$847K0.76%0.14%Not reportedQ1 2021
AHCOAdaptHealth Corp.$818K0.74%0.07%Not reportedQ4 2019
AXSMAxsome Therapeutics, Inc.$787K0.71%0.02%Not reportedQ3 2018
IQVIqvia Holdings Inc.$776K0.70%0.00%-79.4%Q2 2018
OLMAOlema Pharmaceuticals, Inc.$723K0.65%0.11%+45.8%Q2 2023
VTYXVentyx Biosciences, Inc.$641K0.58%0.03%NewQ3 2023
ACLXArcellx, Inc.$508K0.46%0.03%NewQ3 2023
GDRXGoodRx Holdings, Inc.$491K0.44%Not reportedNot reportedQ4 2020
RNACCartesian Therapeutics, Inc.$481K0.43%0.29%-33.9%Q4 2019
NVSTEnvista Holdings Corp$301K0.27%0.01%NewQ3 2023
ADAPYAdaptimmune Therapeutics PLC$243K0.22%0.02%-62.0%Q1 2020
Q2 2023Reported Aug 14, 202328 positions
CICigna Group$7.24M6.32%0.01%-7.1%Q4 2014
MRKMerck & Co., Inc.$5.69M4.97%0.00%-0.5%Q4 2014
AAgilent Technologies, Inc.$5.5M4.80%0.02%Not reportedQ4 2014
THCTenet Healthcare Corp$4.72M4.12%0.06%-3.1%Q1 2019
AZNAstrazeneca PLC$4.35M3.80%Not reported-37.5%Q2 2019
IQVIqvia Holdings Inc.$4.31M3.76%0.01%Not reportedQ2 2018
BMRNBiomarin Pharmaceutical Inc$3.78M3.30%0.02%-82.9%Q1 2017
BDXBecton Dickinson & Co$3.53M3.08%0.00%-82.6%Q4 2014
BSXBoston Scientific Corp$3.3M2.88%0.00%Not reportedQ4 2014
CAHCardinal Health Inc$3M2.62%0.01%Not reportedQ4 2014
QGENQiagen N.V.$2.82M2.47%0.03%-65.0%Q2 2015
ELVElevance Health, Inc.$2.5M2.19%0.00%-84.9%Q4 2014
MDTMedtronic plc$2.39M2.09%0.00%Not reportedQ4 2014
EHCEncompass Health Corp$2.21M1.93%0.03%+23.6%Q4 2018
VTRVentas, Inc.$1.97M1.72%0.01%Not reportedQ3 2022
OCULOcular Therapeutix, Inc$1.9M1.66%0.47%-28.1%Q1 2018
INSMINSMED Inc$1.68M1.46%0.06%-65.5%Q3 2017
ZTSZoetis Inc.$1.32M1.15%0.00%-9.2%Q1 2017
BRKRBruker Corp$1.13M0.98%0.01%Not reportedQ1 2015
ARGXArgenx SE$1M0.87%0.00%-58.2%Q1 2022
RNACCartesian Therapeutics, Inc.$768K0.67%0.45%-68.3%Q4 2019
ADAPYAdaptimmune Therapeutics PLC$759K0.66%0.06%-50.6%Q1 2020
ACHCAcadia Healthcare Company, Inc.$729K0.64%0.01%Not reportedQ4 2016
ETNB89bio, Inc.$555K0.48%0.04%+49.5%Q4 2022
KIDSOrthopediatrics Corp$471K0.41%0.05%Not reportedQ3 2020
MASIMasimo Corp$469K0.41%0.01%Not reportedQ1 2018
OLMAOlema Pharmaceuticals, Inc.$363K0.32%0.10%NewQ2 2023
VKTXViking Therapeutics, Inc.$336K0.29%0.02%-63.6%Q1 2018
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.